Afuco™ Anti-Human TMEM30A ADCC Therapeutic Antibody, ADCC Enhanced

Anti-TMEM30A ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The TMEM30A (CDC-50A) binding antibody was found to greatly enhance transport across the BBB as compared to monovalent FC5 VHH. The antibody can be used for treatment of disorders or diseases having a neurological component.
Supplier Creative Biolabs
Product # AFC-596CL
Pricing Inquiry
Host Human
Target TMEM30A
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at -20°C. Avoid multiple freeze/thaw cycles.
Feedback